Congratulations to Dr. Camille Cohen, for obtaining a Nephro-transplantation Projects grant from the SFNDT – French-Speaking Society of Nephrology, Dialysis and Transplantation

A nephrologist, researcher, and head of the “Kidney Diseases and Monoclonal Immunoglobulins” team at the CRI – Center for Research on Inflammation, Dr. Camille Cohen is also the co-coordinator of the FHU INFIRE.

What is the objective of the winning project?
The InProgCKD project aims to decipher the early signals of inflammation in the kidneys and the interactions between kidney cells that contribute to the development of renal fibrosis, a key step in the worsening of chronic kidney disease. (CKD).

Why is it important?
CKD affects 1 in 10 people worldwide and could become the fifth leading cause of death by 2040.
By combining molecular and histopathological analyses and clinical data from biopsies, InProgCKD seeks to identify new predictive markers of progression and possible innovative therapeutic targets.

This work could pave the way for novel approaches to prevent irreversible deterioration of kidney function, both in transplantation and chronic kidney disease.

Congratulations again to Camille Cohen for this award and for her promising contribution to research in nephrology, dialysis, and transplantation!

Photo credit: SFNDT – Société Francophone de Néphrologie, Dialysis and Transplantation and Mickaël Bobot